You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Bexsero packshot

Product overview

Indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B

Order now

Support materials

A Bexsero administration guide and parent communication checklist to support you and your practice.

Is there a need for meningitis B private vaccination?

GSK has created a series of short videos exploring the burden of the disease, at risk group and in depth look at GSK meningitis B vaccine, Bexsero.

Meningitis B - epidemiology, signs and symptoms.

Who are the patients at risk in the UK?

Overview of Bexsero.

Adverse events should be reported. Reporting forms and information can be found at
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Bexsero is a registered trademark of the GlaxoSmithKline group of companies.